Rare diseases
Investigational molecules
Locations
Dronninggaards Alle 136, 2840, Denmark
Synact Pharma ApS is involved in clinical research for idiopathic membranous nephropathy with severe proteinuria, reflecting an interest in renal conditions marked by persistent loss of protein in the urine and immune-mediated kidney injury.
Its kidney-focused studies address both disease activity and urinary protein excretion as key clinical concerns in nephrology.
Synact Pharma ApS runs clinical trials in conditions such as Glomerulonephritis membranous, Nephrotic syndrome, Polymyalgia rheumatica, Rheumatoid arthritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkDenmark
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
